Impact of early hypothalamic-pituitary-gonadal axis maturation on prostate cancer:Cross-sectional analysis of a Veterans Affairs cohort.

Authors

null

Rimaz M. Khadir

Medical College of Georgia, Augusta, GA

Rimaz M. Khadir , Rashid K. Sayyid , Martha K. Terris

Organizations

Medical College of Georgia, Augusta, GA, Department of Surgery, Section of Urology, Medical College of Georgia, Augusta University, Augusta, GA

Research Funding

No funding received
None.

Background: Early onset of puberty, resulting in more prolonged exposure to higher androgen levels, has been hypothesized to be a risk factor for more aggressive prostate cancer (PCa) later in life. We sought to determine whether earlier age of first shave and height, as surrogates of pubertal onset, were associated with worsening PCa characteristics. Methods: A prospectively collected registry of patients presenting for a prostate biopsy at the Charlie Norwood Veterans Affairs Medical Center in Augusta, GA between July 1995 and June 2016 was utilized. Age of first shave and height were compared to the risk of cancer on prostate biopsy, high grade cancer (i.e. Gleason score 8 or higher), and high volume disease (i.e. at least 50% of total cores were positive) using univariable and multivariable logistic regression analysis, controlling for patient age, race, prostate specific antigen, percent free prostate specific antigen, clinical stage, prostate volume, body mass index, family history. Statistical significance was set at p < 0.05 and all statistical analyses were performed using R version 3.6.1. Results: Of the 1,176 patients analyzed, 599 (50.9%) had a cancer on prostate biopsy, of which 141 (23.5%) and 194 (32.4%) had high grade and volume disease, respectively. Median age of first shave was 17.0 years (interquartile range 16.0-19.0) and height was 177.8 cm (172.7-182.9). On multivariable analysis, later age of first shave was significantly associated with increased odds of a positive prostate biopsy (odds ratio for > 18 years versus < 16 years: 5.36, p = 0.03) and taller patients had significantly increased odds of high-grade cancer (odds ratio for 175-180 cm versus < 175 cm 7.41, p = 0.038). Conclusions: Among patients presenting for a prostate biopsy, those with a later age of first shave and taller height had an increased risk of a positive prostate biopsy and high-grade PCa, respectively. This suggests that patients with later age of puberty, and thus later testosterone surges, are at increased risk of overall and high-grade PCa.

Predictors of presence of cancer on prostate biopsy, high grade cancer, and high volume cancer (multivariable).

Predictors of Presence of Cancer
VariableOR95% CIP-value
Age of first shave (categorical, reference: < 16)
16-181.880.55 – 6.710.32
> 185.361.26 – 25.530.03
Height (categorical, reference: < 175 cm)
175-180 cm1.300.51 – 3.370.59
> 180 cm1.820.80 – 4.240.16
Predictors of High Grade Cancer
Age of first shave (categorical, reference: < 16)
16-180.450.05 – 4.300.48
> 180.170.008 – 2.360.21
Height (categorical, reference: < 175 cm)
175-180 cm7.411.25 – 58.480.038
> 180 cm2.620.62 – 13.190.21
Predictors of High Volume Cancer
Age of first shave (categorical, reference: < 16)
16-1811.560.89 – 23.200.055
> 188.970.79 – 15.320.080
Height (categorical, reference: < 175 cm)
175-180 cm2.340.82 –4.120.13
> 180 cm1.820.78 – 4.930.21

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Prostate Cancer - Localized Disease

Track

Prostate Cancer - Localized

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 255)

DOI

10.1200/JCO.2021.39.6_suppl.255

Abstract #

255

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

Abstract

2022 ASCO Genitourinary Cancers Symposium

Impact of COVID-19 on the incidence of prostate cancer among White and Black Veterans.

First Author: Kyung Min Lee

First Author: Joshua Mabellos

First Author: Michael Vincent Sherer

First Author: Michael Vincent Sherer